Opaleye Management Inc.
Q3 2025 13F Holdings
- Locationboston, MA
- Num holdings
43
- Value ($000)
$707,321
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001595855
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HARROW HEALTH INC | COM | 415858109 | $188.14M | 27 % | 3,905,000 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | $62.15M | 9 % | 2,860,000 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | $59.47M | 8 % | 2,615,000 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $46.63M | 7 % | 461,700 | ||
IMMUNOME INC | COM | 45257U108 | $37.3M | 5 % | 3,185,000 | ||
SANUWAVE HEALTH INC | COM | 80303D305 | $36.73M | 5 % | 980,000 | ||
CODEXIS INC | COM | 192005106 | $31.22M | 4 % | 12,795,000 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $19.33M | 3 % | 535,000 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | $18.65M | 3 % | 1,595,000 | ||
CG ONCOLOGY INC | COM | 156944100 | $16.51M | 2 % | 410,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100